WHO ICTRP trial
An observational cohort study on the efficacy and safety of zonisamide as a…
ChiCTR2100047311 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100047311 |
|---|---|
| Public title | An observational cohort study on the efficacy and safety of zonisamide as a first add-on treatment in focal epilepsy or focal to bilateral tonic clonic seizures |
| Scientific title | An observational cohort study on the efficacy and safety of zonisamide as a first add-on treatment in focal epilepsy or focal to bilateral tonic clonic seizures |
| Primary sponsor | QiLu Hospital of Shandong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Epilepsy |
| Interventions | single arm:zonisamide Oral administration, once or twice daily. Titration period: the initial dose was 100 mg/maintenance dose was 200-400 mg/day, increased by 100 mg/day every 2 weeks, 8 to achieve the target dose, and the maintenance dose… |
| Registration date | Jun 12, 2021 |
| Target size | single arm:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: